In this study, we revealed that the effectiveness of Cat S in the differentiation of GC patients from those with benign gastric diseases and normal controls was superior to the traditional markers of CEA, CA724 and CA199, although the sensitivity of the serum Cat S was not particularly high. The gene discussed is CAT; the disease is gastric cancer.